About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
PROGRESS
PATIENTS
Enabling a better future for people with rare immune disorders
learn more
recent news
X4 Pharmaceuticals to Participate in the Stifel 2024 Healthcare Conference
November 14, 2024
X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)
November 13, 2024
More News
© Copyright 2024 X4 Pharmaceuticals. All Rights Reserved.
Terms of Use
|
Privacy
|
Compliance and Ethics